If and when a safe and effective COVID-19 vaccine becomes available, there will not be enough to vaccinate everyone who wants it. Difficult decisions will have to be made about the allocation of available vaccines both between and within countries. What values should guide vaccine allocation in a world where governments face competing obligations to their own people and to the global community, and in societies where COVID-19 and control measures have such disparate outcomes for different people?
Chair: Mike Parker, Director of the Wellcome Centre for Ethics and Humanities and the ETHOX Centre, University of Oxford
Anant Bhan, Researcher, Global Health, Bioethics, Health Policy, Adjunct Professor, Yenepoya, India
Ruth Faden, Berman Institute Founder, Philip Franklin Wagley Professor of Biomedical Ethics
Sophie Mathewson, Specialist, Vaccine Policy & Investment, GAVI